Sign in
4/A

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-26-099007

President and CEO gave up 7,408 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mahoney Stephen F. President and CEO 2026-03-03 Shares withheld for taxes −7,408 $30.19 $223,648 33,349 D
Loading xslF345X05/ownership.xml…